Icon Group continues its global expansion announcing Singapore Oncology Consultants’ (SOC) incorporation into the Group. SOC currently has a significant share of the private medical oncology market in Singapore.
Icon Group CEO Mark Middleton said SOC is led by some of the most experienced medical oncologists in Singapore and surrounding regions, with the majority of patients travelling to SOC from outside Singapore, testament to the expertise of the pre-eminent medical practitioners.
“SOC currently runs outreach clinics into Myanmar and Vietnam and there are tremendous opportunities to further grow the practice into South-East Asia,” Mr Middleton said.
“The specialists who run SOC are held in high esteem and run practices at four major private hospitals in Singapore. They bring to Icon Group invaluable wisdom and expertise in the Asian healthcare market, and as part of Icon Group, we can now provide these oncologists with additional access to world-leading technology and research and a capacity to grow the range of depth of cancer care services.”
The benefits for patients in Singapore and Asia more broadly include access to an even greater knowledge base of medical specialists with the bringing together of world best practitioners, along with access to latest technology and an opportunity to participate in clinical trials and research.
“Our move into Singapore marks a significant milestone not only for our company but more importantly for cancer patients. There is an acute need for advanced cancer care in Asia and I know that our people, expertise and commitment to patients are second to none. Bringing SOC into the Icon Group and partnering with Yibai Healthcare means we will have an unparalleled knowledge base for cancer care in the Asian region.”
The incorporation of SOC into Icon Group is subject to confirmatory and regulatory approval.